Hereditary cancer syndromes account for approximately 5%–10% of all malignancies and have long been characterized by monogenic inheritance patterns, wherein a pathogenic variant in a single high-penetrance gene (e.g., BRCA1, BRCA2, TP53) confers a significantly elevated lifetime risk of specific cancers. Here, BRCA1 is linked to cancer.